Natixis »

Celldex Therapeutics shares owned by Natixis

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Natixis

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.0M 214k 41.97

More positions owned by Natixis

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Coinbase Global Com Cl A (COIN)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Select Sector Spdr Tr Indl (XLI)
Energy Transfer Com Ut Ltd Ptn (ET)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Cisco Systems (CSCO)
Meta Platforms Cl A (META)

View all positions for Natixis

Top funds holding Celldex Therapeutics

FMR
Wellington Management Company
BlackRock
Vanguard Group
Eventide Asset Management
T. Rowe Price Associates
Kynam Capital Management
Bellevue Group
Pictet Asset Management Holding SA
Geode Capital Management
Rock Springs Capital Management
Point72 Asset Management
Marshall Wace
Redmile Group
Commodore Capital

View all funds holding Celldex Therapeutics